TABLE 1.
Demographics | Tegoprazan | Placebo | |
---|---|---|---|
50 mg (n = 106) | 100 mg (n = 99) | (n = 99) | |
Age (years) | 45.4 (12.2) | 44.1 (13.3) | 45.6 (13.3) |
Male (%) | 31 (29.3) | 37 (37.4) | 31 (31.3) |
Height (cm) | 163.5 (8.8) | 164.4 (8.4) | 163.9 (8.2) |
Weight (kg) | 61.3 (10.8) | 63.3 (11.8) | 62.7 (12.1) |
Body mass index (kg/m2) | 22.9 (3.2) | 23.3 (3.4) | 23.2 (3.0) |
≥25 and ≤30, n (%) | 22 (20.8) | 20 (20.2) | 27 (27.3) |
>30, n (%) | 2 (1.9) | 4 (4.0) | 1 (1.0) |
Smoking, n (%) | 12 (11.3) | 19 (19.2) | 11 (11.1) |
Alcohol consumption, n (%) | 33 (31.1) | 39 (39.4) | 33 (33.3) |
Values are presented as mean (standard deviation) except for gender, smoking, and alcohol consumption, which were presented as mean (%).
Abbreviation: n, number of patients.